Neither B lymphocytes nor antibodies directed against self antigens of theislets of langerhans are required for development of virus-induced autoimmune diabetes
A. Holz et al., Neither B lymphocytes nor antibodies directed against self antigens of theislets of langerhans are required for development of virus-induced autoimmune diabetes, J IMMUNOL, 165(10), 2000, pp. 5945-5953
We evaluated the role of the humoral arm of the immune response in causing
or contributing to virus-induced diabetes. Transgenic mire expressing the n
ucleoprotein (NP) or glycoprotein (GP) of the lymphocytic choriomeningitis
virus (LCR IV) under control of the rat insulin promoter (RIP) in pancreati
c beta cells (RIP-LCMV) and RIP-LCMV mice with genetic dysfunction of B cel
ls (RIP-LCMV x mu MT/mu MT) were compared for development of diabetes after
challenge with LCMV, After inoculation with LCMV, B and T lymphocytes and
macrophages infiltrated into pancreatic islets in RIP-LCMV mice, and over 5
0% of these mice generated Abs against host insulin or glutamate decarboxyl
ase. However, neither B cells nor the autoantibodies played a direct role i
n the initiation, kinetics, or severity of the virus-induced diabetes as ju
dged by comparing disease in RIP-LCR IV mice to littermates whose functiona
l B cells were genetically eliminated. Furthermore, the quality and quantit
y of T lymphocyte and macrophage infiltration was similar in the B cell-def
icient and non-B cell-deficient RIP-LCMV mice. Although the development of
autoantibodies to islet Ags had no direct influence on the pathogenesis of
insulin-dependent (type 1) diabetes mellitus, it served as a prediabetes ma
rker, as such autoantibodies were often elevated before the onset of diseas
e. Hence, the RIP-LCMV model is not only useful for understanding the patho
genetic mechanisms of how islets are destroyed and spared but also for eval
uating therapeutic strategies before onset of clinical diabetes.